Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
3(30%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_4
2
20%
Ph not_applicable
3
30%
Ph phase_1
1
10%
Ph phase_3
2
20%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(6)
Other(1)

Detailed Status

Completed6
Recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 32 (25.0%)
Phase 42 (25.0%)
N/A3 (37.5%)

Trials by Status

completed660%
unknown110%
recruiting330%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10